Cevimeline hydrochloride hemihydrate T2390
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Cevimeline hydrochloride hemihydrate is a novel muscarinic receptor agonist, used as a candidate therapeutic drug for xerostomia in Sjogren's syndrome.
CAS nr:
153504-70-2
Purity:
98%
Molecular Weight:
489,55
SMILES:
O.Cl.Cl.C[C@@H]1O[C@]2(CS1)CN1CCC2CC1.C[C@@H]1O[C@]2(CS1)CN1CCC2CC1
Formula:
C20H38Cl2N2O3S2
Pathway:
Neuroscience
Target:
AChR
